Published in Vaccine Weekly, February 26th, 2003
"From January 29, 1987 to January 25, 1997, 180 patients diagnosed with astrocytoma with anaplastic foci (AAF) and glioblastoma multiforme (GBM) were treated as outpatients with an average of three weekly intravenous or intraarterial injections of radiolabeled MAb 425," stated Jacqueline G. Emrich and colleagues at Drexel University, Temple University, and Thomas Jefferson University in Philadelphia. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly